EMA/PE/0000232771
Submitted by Anonymous (not verified) on 4 June 2026 - 13:38
EMA/PE/0000232771
EMA/PE/0000232769
Submitted by Anonymous (not verified) on 4 June 2026 - 13:38
EMA/PE/0000232769
Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Date of authorisation: 15/04/2026, Revision: 1, Status: Authorised
Submitted by Anonymous (not verified) on 4 June 2026 - 13:38
Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Date of authorisation: 15/04/2026, Revision: 1, Status: Authorised
EMA/PE/0000232764
Submitted by Anonymous (not verified) on 4 June 2026 - 13:35
EMA/PE/0000232764
EMA/PE/0000232763
Submitted by Anonymous (not verified) on 4 June 2026 - 12:48
EMA/PE/0000232763
EMA/PE/0000232638
Submitted by Anonymous (not verified) on 4 June 2026 - 12:48
EMA/PE/0000232638
EMA/PE/0000232759
Submitted by Anonymous (not verified) on 4 June 2026 - 12:48
EMA/PE/0000232759
EMA/PE/0000232171
Submitted by Anonymous (not verified) on 4 June 2026 - 12:44
EMA/PE/0000232171
2025 AI Observatory report
Submitted by Anonymous (not verified) on 4 June 2026 - 11:33
2025 AI Observatory report
Standard operating procedure for the contribution to the 3-yearly JIACRA reports
Submitted by Anonymous (not verified) on 4 June 2026 - 10:20
Standard operating procedure for the contribution to the 3-yearly JIACRA reports